Rheumatology
Conference Coverage
Fractures beget fractures at any age
From a person’s 20s to their 80s, the increased risk of fracture after a prior fracture may not be significantly different.
From the Journals
Abatacept, certolizumab: Best biologics in early RA
The study was the first head-to-head comparison of multiple biologics plus methotrexate vs. active conventional DMARDs plus steroid bridging for...
From the Journals
Biomarkers may help women with RA to decide on medications in pregnancy
Researchers find differences in gene expression before pregnancy that could help women with rheumatoid arthritis choose to stop or continue...
From the Journals
Anemia, iron deficit common in rheumatic disease pregnancy
Low maternal levels of hemoglobin and serum ferritin in pregnancy were associated with adverse infant outcomes.
News from the FDA/CDC
Intravenous formulation of secukinumab gets FDA approval
This new route of administration is expected to become available during the fourth quarter of 2023.
From the Journals
Adverse event rates compared for colchicine, NSAIDs when starting allopurinol for gout
Patients receiving prophylactic colchicine or NSAIDs with initiation of allopurinol for gout have more adverse events than those who receive no...
From the Journals
More evidence shows COVID-19’s link to risk for autoimmune disease
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several...
News from the FDA/CDC
FDA approves ninth Humira biosimilar, with interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late...
Commentary
Rheumatoid arthritis: Five things to know
A healthier lifestyle is associated with a reduced risk of developing rheumatoid arthritis.
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
From the Journals
Early glucocorticoid bridging in RA supported by meta-analysis, but concerns remain
Conflicting view: A coauthor of the 2021 American College of Rheumatology guideline says glucocorticoid treatment should be avoided if at all...